Assembly Biosciences announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer. Dr. Gaggar is an infectious disease specialist and seasoned executive whose experience has focused on the development of new therapies in viral diseases including chronic hepatitis B virus, hepatitis C virus and hepatitis D virus infections. Dr. Gaggar joins from Arrive Bio, a private early-stage biotechnology company that he co-founded and served as chief executive officer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ASMB: